<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32862270</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases.</ArticleTitle><Pagination><StartPage>777</StartPage><EndPage>781</EndPage><MedlinePgn>777-781</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-020-02216-9</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dedeene</LastName><ForeName>Lieselot</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0545-8072</Identifier><AffiliationInfo><Affiliation>Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Department of Imaging and Pathology, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), O&amp;N IV Herestraat 49-Bus 1032, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neurobiology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain and Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Schoor</LastName><ForeName>Evelien</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Department of Imaging and Pathology, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), O&amp;N IV Herestraat 49-Bus 1032, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neurobiology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain and Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ospitalieri</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Department of Imaging and Pathology, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), O&amp;N IV Herestraat 49-Bus 1032, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronisz</LastName><ForeName>Alicja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Department of Imaging and Pathology, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), O&amp;N IV Herestraat 49-Bus 1032, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otto</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheuerle</LastName><ForeName>Angelika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Pathology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandenberghe</LastName><ForeName>Rik</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Cognitive Neurology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory for Neurobiology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain and Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poesen</LastName><ForeName>Koen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Dietmar Rudolf</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-1036-1075</Identifier><AffiliationInfo><Affiliation>Laboratory for Neuropathology, Department of Imaging and Pathology, Leuven Brain Institute (LBI), KU Leuven (University of Leuven), O&amp;N IV Herestraat 49-Bus 1032, 3000, Leuven, Belgium. dietmar.thal@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University Hospitals Leuven, Leuven, Belgium. dietmar.thal@kuleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007030" MajorTopicYN="N">Hypothalamo-Hypophyseal System</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32862270</ArticleId><ArticleId IdType="doi">10.1007/s00401-020-02216-9</ArticleId><ArticleId IdType="pii">10.1007/s00401-020-02216-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ash PEA, Bieniek KF, Gendron TF, Caulfield T, Lin W-L, DeJesus-Hernandez M et al (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77:639&#x2013;646. https://doi.org/10.1016/j.neuron.2013.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId><ArticleId IdType="pmc">3593233</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol 14:544&#x2013;558. https://doi.org/10.1038/s41582-018-0047-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId><ArticleId IdType="pmc">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilic E, Bilic E, Rudan I, Kusec V, Zurak N, Delimar D et al (2006) Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls. Eur J Neurol 13:1340&#x2013;1345. https://doi.org/10.1111/j.1468-1331.2006.01503.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2006.01503.x</ArticleId><ArticleId IdType="pubmed">17116217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Takei H, Schulz PE, Appel SH, Powell SZ (2014) TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun 2:171. https://doi.org/10.1186/s40478-014-0171-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0171-1</ArticleId><ArticleId IdType="pubmed">25539830</ArticleId><ArticleId IdType="pmc">4297460</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pablo-Fernandez E, Courtney R, Holton JL, Warner TT (2017) Hypothalamic &#x3b1;-synuclein and its relation to weight loss and autonomic symptoms in Parkinson&#x2019;s disease. Mov Disord 32:296&#x2013;298. https://doi.org/10.1002/mds.26868</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26868</ArticleId><ArticleId IdType="pubmed">27892607</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedeene L, Van Schoor E, Race V, Moisse M, Vandenberghe R, Poesen K et al (2019) An ALS case with 38 (G4C2)-repeats in the C9orf72 gene shows TDP-43 and sparse dipeptide repeat protein pathology. Acta Neuropathol 137:855&#x2013;858. https://doi.org/10.1007/s00401-019-01996-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01996-z</ArticleId><ArticleId IdType="pubmed">30919029</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedeene L, Van Schoor E, Vandenberghe R, Van Damme P, Poesen K, Thal DR (2019) Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases. Acta Neuropathol Commun 7:189. https://doi.org/10.1186/s40478-019-0845-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0845-9</ArticleId><ArticleId IdType="pubmed">31791419</ArticleId><ArticleId IdType="pmc">6889626</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245&#x2013;256. https://doi.org/10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId><ArticleId IdType="pmc">3202986</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez De Aguilar JL, Ren&#xe9; F, Dupuis L, Loeffler JP (2003) Neuroendocrinology of neurodegenerative diseases: insights from transgenic mouse models. Neuroendocrinology 78:244&#x2013;252. https://doi.org/10.1159/000074445</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000074445</ArticleId><ArticleId IdType="pubmed">14657605</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma T, Mochizuki Y, Mizutani T (2012) Phosphorylated &#x3b1;-synuclein immunoreactivity in the posterior pituitary lobe. Neuropathology 32:385&#x2013;389. https://doi.org/10.1111/j.1440-1789.2011.01273.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2011.01273.x</ArticleId><ArticleId IdType="pubmed">22082318</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VMY et al (2013) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70:462&#x2013;468. https://doi.org/10.1001/jamaneurol.2013.1933</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.1933</ArticleId><ArticleId IdType="pubmed">23380910</ArticleId><ArticleId IdType="pmc">3678373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii M, Iadecola C (2015) Metabolic and non-cognitive manifestations of Alzheimers disease: the hypothalamus as both culprit and target of pathology. Cell Metab 22:761&#x2013;776. https://doi.org/10.1016/j.cmet.2015.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.08.016</ArticleId><ArticleId IdType="pubmed">26365177</ArticleId><ArticleId IdType="pmc">4654127</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K et al (2013) Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol 126:859&#x2013;879. https://doi.org/10.1007/s00401-013-1181-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1181-y</ArticleId><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrofanova LB, Konovalov PV, Krylova JS, Polyakova VO, Kvetnoy IM (2017) Plurihormonal cells of normal anterior pituitary: facts and conclusions. Oncotarget 8:29282&#x2013;29299. https://doi.org/10.18632/oncotarget.16502</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.16502</ArticleId><ArticleId IdType="pubmed">28418929</ArticleId><ArticleId IdType="pmc">5438730</ArticleId></ArticleIdList></Reference><Reference><Citation>Morselli LL, Bongioanni P, Genovesi M, Licitra R, Rossi B, Murri L et al (2006) Growth hormone secretion is impaired in amyotrophic lateral sclerosis. Clin Endocrinol (Oxf) 65:385&#x2013;388. https://doi.org/10.1111/j.1365-2265.2006.02609.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2006.02609.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130&#x2013;133. https://doi.org/10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Newhouse A, Chemali Z (2020) Neuroendocrine disturbances in neurodegenerative disorders: a scoping review. Psychosomatics 61:105&#x2013;115. https://doi.org/10.1016/j.psym.2019.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psym.2019.11.002</ArticleId><ArticleId IdType="pubmed">31918850</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellecchia MT, Pivonello R, Monsurr&#xf2; MR, Trojsi F, Longo K, Piccirillo G et al (2010) The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features. Eur J Neurol 17:666&#x2013;671. https://doi.org/10.1111/j.1468-1331.2009.02896.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02896.x</ArticleId><ArticleId IdType="pubmed">20002733</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Jiang J, Garcia SD, Taylor AE, Schulte D et al (2018) Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol 135:459&#x2013;474. https://doi.org/10.1007/s00401-017-1793-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacc&#xe0; F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Perrotta G et al (2012) A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. J Neurol 259:132&#x2013;138. https://doi.org/10.1007/s00415-011-6146-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6146-2</ArticleId><ArticleId IdType="pubmed">21706151</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakae N, Bieniek KF, Zhang YJ, Ross K, Gendron TF, Murray ME et al (2018) Poly-GR dipeptide repeat polymers correlate with neurodegeneration and clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathol Commun 6:63. https://doi.org/10.1186/s40478-018-0564-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0564-7</ArticleId><ArticleId IdType="pubmed">30029693</ArticleId><ArticleId IdType="pmc">6054740</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampognaro PJ, Vatsavayai SC, Cosme CG, Hwang JHL, Nolan A, Huang EJ et al (2019) C9orf72-specific phenomena associated with frontotemporal dementia and gastrointestinal symptoms in the absence of TDP-43 aggregation. Acta Neuropathol 138:1093&#x2013;1097. https://doi.org/10.1007/s00401-019-02084-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02084-y</ArticleId><ArticleId IdType="pubmed">31624869</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, May S, Gr&#xe4;sser FA, Rentzsch K, Kremmer E, K&#xfc;pper C, German Consortium for Frontotemporal Lobar Degeneration, Bavarian Brain Banking Alliance et al (2015) Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol 130:537&#x2013;555. https://doi.org/10.1007/s00401-015-1450-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1450-z</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId><ArticleId IdType="pmc">4575390</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JNS, Trujillo A et al (2016) Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain 139:3202&#x2013;3216. https://doi.org/10.1093/brain/aww250</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww250</ArticleId><ArticleId IdType="pubmed">27797809</ArticleId><ArticleId IdType="pmc">5790143</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>